American College of Clinical Pharmacy
      Search      Cart
         

Endocrine and Metabolism PRN Focus Session -- Into the Wild: Navigating the Jungles of Vascular Outcomes, Mountains of Adiposity, and Zebras of Diabetes

Saturday, October 26, 2019 from 3:30 PM to 5:00 PM EST at 3rd Floor: Rendezvous Trianon

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-19-175-L01-P
Activity Type: An Application-Based Activity


Speakers
  • Diana Isaacs, Pharm.D., BCPSModerator: Diana Isaacs, Pharm.D., BCPS
    Clinical Pharmacy Specialist, Endocrinology & Metabolism Institute, Diabetes Center, Cleveland Clinic, Cleveland, Ohio
      View Biography

Navigating the Jungles of Vascular Outcomes
3:30 PM

Speakers
  • Dave L. Dixon, Dave L. Dixon, Pharm.D., BCPS, FCCPSpeaker: Dave L. Dixon, Dave L. Dixon, Pharm.D., BCPS, FCCP
    Associate Professor, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia
      View Biography


Learning Objectives
1. Compare and contrast varying characteristics and vascular outcomes of clinical trials with diabetes agents.
2. Apply vascular outcome literature findings to patient case scenarios in diabetes management.
Climbing the Mountains of Adiposity to Achieve Optimal Outcomes in Obesity
4:00 PM

Speakers
  • Brian K. Irons, Pharm.D., FCCP, BCACP,Speaker: Brian K. Irons, Pharm.D., FCCP, BCACP,
    Professor of Pharmacy Practice, Texas Tech University Health Sciences Center, Lubbock, Texas
      View Biography


Learning Objectives
1. Interpret new literature of surgical and non-surgical options to treat obesity.
2. Recommend the best treatment plan for patient case scenarios in obesity.
Treating the Zebras of Diabetes
4:30 PM

Speakers
  • Jennifer M. Trujillo, Pharm.D., BCPS, CDESpeaker: Jennifer M. Trujillo, Pharm.D., BCPS, CDE
    Professor, University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado
      View Biography


Learning Objectives
1. Identify the less common forms of diabetes and the pathophysiology behind them.
2. Explain the differences in treatment strategies of the less common forms of diabetes.